New Key Statistics Module, Z-Score and F-Score
NAS:HBIO Key Ratios
Market Cap $ M | 171.73 |
Enterprise Value $ M | 208.70 |
P/E(ttm) | -- |
PE Ratio without NRI | 158.20 |
Forward PE Ratio | -- |
Price/Book | 2.35 |
Price/Sales | 1.50 |
Price/Free Cash Flow | 14.39 |
Price/Owner Earnings | 23.28 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 112.00 |
EPS (TTM) $ | -0.08 |
Beneish M-Score | -3.09 |
10-y EBITDA Growth Rate % | -1.80 |
5-y EBITDA Growth Rate % | -12.40 |
y-y EBITDA Growth Rate % | 721.70 |
EV-to-EBIT | 199.34 |
EV-to-EBITDA | 25.68 |
PEG | -- |
Shares Outstanding M | 43.42 |
Net Margin (%) | -3.04 |
Operating Margin % | 1.69 |
Pre-tax Margin (%) | -2.28 |
Quick Ratio | 0.92 |
Current Ratio | 1.85 |
ROA % (ttm) | -2.40 |
ROE % (ttm) | -4.62 |
ROIC % (ttm) | 1.92 |
Dividend Yield % | -- |
Altman Z-Score | 1.14 |
HBIO Number of Guru Trades
HBIO Volume of Guru Trades
Gurus Latest Trades with NAS:HBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HBIO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Harvard Bioscience Inc Insider Transactions
No Available Data
News about NAS:HBIO
Total 0- 1